ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,377, issued on May 26, was assigned to Pfizer Inc. (New York).

"Anti-EDB antibodies and antibody-drug conjugates" was invented by Andrea Therese Hooper (Port Chester, N.Y.), Kimberly Ann Marquette (Somerville, Mass.), Chakrapani Subramanyam (South Glastonbury, Conn.), Hans-Peter Gerber (San Carlos, Calif.) and Chad Michael May (Belmont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides antibodies and antibody-drug conjugates that bind to the extra domain B splice variant of fibronectin 1 and methods for preparing and using the same."

The patent was filed on Oct. 23, 2023, under Application No. 18/492,348.

*For fur...